Anbenitamab [2367012-88-0]

MedChem Express

Anbenitamab [2367012-88-0]

10

2367012-88-0

Research Use Only

99.22

Anbenitamab (KN-026) is a bispecific antibody simultaneously targeting extracellular domains II and IV of human HER2. Anbenitamab blocks both ligand-dependent and ligand-independent HER2 signaling pathways. Anbenitamab mediates antibody-dependent cellular cytotoxicity (ADCC) via FcgammaIIIa binding. Ambrinitumab can be used in research for lung cancer, HER2-positive metastatic breast cancer (MBC), gastric cancer, and gastroesophageal junction cancer[1][2][3][4].

-80°C

41116161